Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaFrancesco Lo‐Coco, Uwe Platzbecker, Giorgina Specchia et al.|New England Journal of Medicine|2013Cited by 1.6k
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti et al.|Blood|2011Cited by 460
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Enrico Maria Trecarichi et al.|Clinical Infectious Diseases|2018Cited by 351
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 TrialR. Willemze, Théo de Witte, Stefan Suciu et al.|Journal of Clinical Oncology|2013Cited by 168
Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvementSimona Soverini, Giovanni Martinelli, Caterina De Benedittis et al.|Cancer|2013Cited by 143